Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H21F2N3OS |
| Molecular Weight | 401.473 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC(F)=C2OC[C@@H](CC2=C1)N3C(=S)NC=C3CCNCC4=CC=CC=C4
InChI
InChIKey=ZSSLCFLHEFXANG-GOSISDBHSA-N
InChI=1S/C21H21F2N3OS/c22-16-8-15-9-18(13-27-20(15)19(23)10-16)26-17(12-25-21(26)28)6-7-24-11-14-4-2-1-3-5-14/h1-5,8,10,12,18,24H,6-7,9,11,13H2,(H,25,28)/t18-/m1/s1
Zamicastat (also known as BIA 5-1058) is a dopamine β-hydroxylase (DβH) inhibitor that decreases noradrenaline and increases dopamine levels in peripheral sympathetically innervated tissues. It is known that the use of DβH inhibitors is a promising approach to treat hypertension, heart failure and cardiovascular diseases where a reduction in the sympathetic tone has beneficial effects. Zamicastat participated in phase II clinical trials in pulmonary arterial hypertension as adjuvant therapy in Austria. In addition, the drug successfully completed phase I in patients with hypertension and chronic heart failure.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02151994
BIA 5-1058 (Zamicastat) (5, 25 and 100 mg) tablets
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
693619
Created by
admin on Mon Mar 31 21:29:26 GMT 2025 , Edited by admin on Mon Mar 31 21:29:26 GMT 2025
|
||
|
NCI_THESAURUS |
C471
Created by
admin on Mon Mar 31 21:29:26 GMT 2025 , Edited by admin on Mon Mar 31 21:29:26 GMT 2025
|
||
|
NCI_THESAURUS |
C270
Created by
admin on Mon Mar 31 21:29:26 GMT 2025 , Edited by admin on Mon Mar 31 21:29:26 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9684
Created by
admin on Mon Mar 31 21:29:26 GMT 2025 , Edited by admin on Mon Mar 31 21:29:26 GMT 2025
|
PRIMARY | |||
|
25052630
Created by
admin on Mon Mar 31 21:29:26 GMT 2025 , Edited by admin on Mon Mar 31 21:29:26 GMT 2025
|
PRIMARY | |||
|
100000177211
Created by
admin on Mon Mar 31 21:29:26 GMT 2025 , Edited by admin on Mon Mar 31 21:29:26 GMT 2025
|
PRIMARY | |||
|
1080028-80-3
Created by
admin on Mon Mar 31 21:29:26 GMT 2025 , Edited by admin on Mon Mar 31 21:29:26 GMT 2025
|
PRIMARY | |||
|
C152947
Created by
admin on Mon Mar 31 21:29:26 GMT 2025 , Edited by admin on Mon Mar 31 21:29:26 GMT 2025
|
PRIMARY | |||
|
YLU32D0DNV
Created by
admin on Mon Mar 31 21:29:26 GMT 2025 , Edited by admin on Mon Mar 31 21:29:26 GMT 2025
|
PRIMARY | |||
|
DTXSID80148358
Created by
admin on Mon Mar 31 21:29:26 GMT 2025 , Edited by admin on Mon Mar 31 21:29:26 GMT 2025
|
PRIMARY | |||
|
DB12389
Created by
admin on Mon Mar 31 21:29:26 GMT 2025 , Edited by admin on Mon Mar 31 21:29:26 GMT 2025
|
PRIMARY |
ACTIVE MOIETY